000904377 001__ 904377
000904377 005__ 20250813092739.0
000904377 0247_ $$2doi$$a10.1007/s00415-021-10722-3
000904377 0247_ $$2ISSN$$a0012-1037
000904377 0247_ $$2ISSN$$a0340-5354
000904377 0247_ $$2ISSN$$a0939-1517
000904377 0247_ $$2ISSN$$a1432-1459
000904377 0247_ $$2ISSN$$a1619-800X
000904377 0247_ $$2Handle$$a2128/30815
000904377 0247_ $$2altmetric$$aaltmetric:112416305
000904377 0247_ $$2pmid$$apmid:34328545
000904377 0247_ $$2WOS$$aWOS:000679613600002
000904377 037__ $$aFZJ-2021-05947
000904377 082__ $$a610
000904377 1001_ $$0P:(DE-HGF)0$$aAdler, Christoph$$b0
000904377 245__ $$aAbsolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest
000904377 260__ $$aBerlin$$bSpringer$$c2022
000904377 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2021-07-30
000904377 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2022-03-01
000904377 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2022-03-01
000904377 3367_ $$2DRIVER$$aarticle
000904377 3367_ $$2DataCite$$aOutput Types/Journal article
000904377 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1646143726_3719
000904377 3367_ $$2BibTeX$$aARTICLE
000904377 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000904377 3367_ $$00$$2EndNote$$aJournal Article
000904377 520__ $$aAbstractObjectives: To test if the early kinetics of neurofilament light (NFL) in blood adds to the absolute values of NFL in the prediction of outcome, and to evaluate if NFL can discriminate individuals with severe hypoxic-ischemic brain injury (sHIBI) from those with other causes of poor outcome after out-of-hospital cardiac arrest (OHCA).Design and setting: Monocentric retrospective study involving individuals following non-traumatic OHCA between April 2014 and April 2016. NFL concentrations were determined on a SiMoA HD-1 device using NF-Light Advantage Kits.Participants: Of 73 patients screened, 53 had serum samples available for NFL measurement at three timepoints (after 3, 24, and 48 h of admission). Of these 53 individuals, 43.4% had poor neurologic outcome at discharge as assessed by Glasgow-Pittsburgh cerebral performance categories, and, according to a current prognostication algorithm, poor outcome due to sHIBI in 20.7%.Main outcome measure: Blood NFL and its early kinetics for prognostication of outcome and prediction of sHIBI after OHCA.Results: An absolute NFL > 508.6 pg/ml 48 h after admission, or a change in NFL > 494 pg/ml compared with an early baseline value predicted outcome, and discriminated severe sHIBI from other causes of unfavorable outcome after OHCA with high sensitivity (100%, 95%CI 70.0-100%) and specificity (91.7%, 95%CI 62.5-100%).Conclusions: Not only absolute values of NFL, but also early changes in NFL predict the outcome following OHCA, and may differentiate sHIBI from other causes of poor outcome after OHCA with high sensitivity and specificity. Our study adds to published data, overall corroborating that NFL measured in blood should be implemented in prognostication algorithms used in clinical routine.Keywords: Brain hypoxia; Cerebral hypoxia; Hypoxic–ischemic brain injury; NFL.
000904377 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000904377 542__ $$2Crossref$$i2021-07-30$$uhttps://creativecommons.org/licenses/by/4.0
000904377 542__ $$2Crossref$$i2021-07-30$$uhttps://creativecommons.org/licenses/by/4.0
000904377 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000904377 7001_ $$0P:(DE-HGF)0$$aOnur, Oezguer A.$$b1
000904377 7001_ $$0P:(DE-HGF)0$$aBraumann, Simon$$b2
000904377 7001_ $$0P:(DE-HGF)0$$aGramespacher, Hannes$$b3
000904377 7001_ $$0P:(DE-HGF)0$$aBittner, Stefan$$b4
000904377 7001_ $$0P:(DE-HGF)0$$aFalk, Steffen$$b5
000904377 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b6$$ufzj
000904377 7001_ $$0P:(DE-HGF)0$$aBaldus, Stephan$$b7
000904377 7001_ $$00000-0002-3510-9255$$aWarnke, Clemens$$b8$$eCorresponding author
000904377 77318 $$2Crossref$$3journal-article$$a10.1007/s00415-021-10722-3$$bSpringer Science and Business Media LLC$$d2021-07-30$$n3$$p1530-1537$$tJournal of Neurology$$v269$$x0340-5354$$y2021
000904377 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-021-10722-3$$n3$$p1530-1537$$tJournal of neurology$$v269$$x0340-5354$$y2022
000904377 8564_ $$uhttps://juser.fz-juelich.de/record/904377/files/Adler2022_Article_AbsoluteSerumNeurofilamentLigh.pdf$$yOpenAccess
000904377 909CO $$ooai:juser.fz-juelich.de:904377$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000904377 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000904377 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000904377 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000904377 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000904377 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2015
000904377 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000904377 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000904377 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000904377 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000904377 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000904377 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000904377 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000904377 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000904377 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000904377 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000904377 9141_ $$y2022
000904377 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b6$$kFZJ
000904377 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000904377 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000904377 980__ $$ajournal
000904377 980__ $$aVDB
000904377 980__ $$aUNRESTRICTED
000904377 980__ $$aI:(DE-Juel1)INM-3-20090406
000904377 9801_ $$aFullTexts
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00134-020-06224-x$$uSandroni C, Grippo A, Nolan JP (2020) ERC-ESICM guidelines for prognostication after cardiac arrest: time for an update. Intensive Care Med 46:1901–1903. https://doi.org/10.1007/s00134-020-06224-x
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.resuscitation.2017.05.014$$uDragancea I, Wise MP, Al-Subaie N, Cranshaw J, Friberg H, Glover G, Pellis T, Rylance R, Walden A, Nielsen N, Cronberg T, investigators TTM (2017) Protocol-driven neurological prognostication and withdrawal of life-sustaining therapy after cardiac arrest and targeted temperature management. Resuscitation 117:50–57. https://doi.org/10.1016/j.resuscitation.2017.05.014
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1097/CCM.0000000000000540$$uMulder M, Gibbs HG, Smith SW, Dhaliwal R, Scott NL, Sprenkle MD, Geocadin RG (2014) Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia*. Crit Care Med 42:2493–2499. https://doi.org/10.1097/CCM.0000000000000540
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.resuscitation.2021.02.012$$uNolan JP, Sandroni C, Bottiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, Nikolaou N, Mariero Olasveengen T, Skrifvars MB, Taccone F, Soar J (2021) European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: post-resuscitation care. Resuscitation 161:220–269. https://doi.org/10.1016/j.resuscitation.2021.02.012
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1038/s41582-018-0058-z$$uKhalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577–589. https://doi.org/10.1038/s41582-018-0058-z
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.ebiom.2020.102807$$uBittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A, Luessi F, Berthele A, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Linker R, Heesen C, Stangel M, Wildemann B, Then Bergh F, Tackenberg B, Kuempfel T, Weber F, Zettl UK, Ziemann U, Tumani H, Groppa S, Muhlau M, Lukas C, Hemmer B, Wiendl H, Gold R, Zipp F, consortium K (2020) Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study. EBioMedicine 56:102807. https://doi.org/10.1016/j.ebiom.2020.102807
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1161/STROKEAHA.119.026410$$uUphaus T, Bittner S, Groschel S, Steffen F, Muthuraman M, Wasser K, Weber-Kruger M, Zipp F, Wachter R, Groschel K (2019) NfL (Neurofilament Light Chain) levels as a predictive marker for long-term outcome after ischemic stroke. Stroke 50:3077–3084. https://doi.org/10.1161/STROKEAHA.119.026410
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/jamaneurol.2018.3223$$uMoseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, Dragancea I, Friberg H, Lilja G, Insel PS, Rylander C, Westhall E, Kjaergaard J, Wise MP, Hassager C, Kuiper MA, Stammet P, Wanscher MCJ, Wetterslev J, Erlinge D, Horn J, Pellis T, Cronberg T (2019) Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol 76:64–71. https://doi.org/10.1001/jamaneurol.2018.3223
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.ijcard.2012.12.016$$uRana OR, Schroder JW, Baukloh JK, Saygili E, Mischke K, Schiefer J, Weis J, Marx N, Rassaf T, Kelm M, Shin DI, Meyer C, Saygili E (2013) Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest. Int J Cardiol 168:1322–1327. https://doi.org/10.1016/j.ijcard.2012.12.016
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00134-020-06218-9$$uWihersaari L, Ashton NJ, Reinikainen M, Jakkula P, Pettila V, Hastbacka J, Tiainen M, Loisa P, Friberg H, Cronberg T, Blennow K, Zetterberg H, Skrifvars MB, Comacare Study G (2021) Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial. Intensive Care Med 47:39–48. https://doi.org/10.1007/s00134-020-06218-9
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/s13054-021-03459-y$$uHunziker S, Quinto A, Ramin-Wright M, Becker C, Beck K, Vincent A, Tisljar K, Disanto G, Benkert P, Leppert D, Pargger H, Marsch S, Raoul S, Peters N, Kuhle J (2021) Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study. Crit Care 25:32. https://doi.org/10.1186/s13054-021-03459-y
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/s13054-018-2042-9$$uAdler C, Heller T, Schregel F, Hagmann H, Hellmich M, Adler J, Reuter H (2018) TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors. Crit Care 22:126. https://doi.org/10.1186/s13054-018-2042-9
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1161/01.CIR.0000147236.85306.15$$uJacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, Cassan P, Coovadia A, D'Este K, Finn J, Halperin H, Handley A, Herlitz J, Hickey R, Idris A, Kloeck W, Larkin GL, Mancini ME, Mason P, Mears G, Monsieurs K, Montgomery W, Morley P, Nichol G, Nolan J, Okada K, Perlman J, Shuster M, Steen PA, Sterz F, Tibballs J, Timerman S, Truitt T, Zideman D, International Liaison Committee on R, American Heart A, European Resuscitation C, Australian Resuscitation C, New Zealand Resuscitation C, Heart, Stroke Foundation of C, InterAmerican Heart F, Resuscitation Councils of Southern A, Arrest ITFoC, Cardiopulmonary Resuscitation O (2004) Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 110:3385–3397: https://doi.org/10.1161/01.CIR.0000147236.85306.15
000904377 999C5 $$1B Jennett$$2Crossref$$9-- missing cx lookup --$$a10.1016/s0140-6736(75)92830-5$$p480 -$$tLancet$$uJennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484. https://doi.org/10.1016/s0140-6736(75)92830-5$$v1$$y1975
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.resuscitation.2005.06.005$$uLanghelle A, Nolan J, Herlitz J, Castren M, Wenzel V, Soreide E, Engdahl J, Steen PA, Utstein Consensus S (2005) Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style. Resuscitation 66:271–283. https://doi.org/10.1016/j.resuscitation.2005.06.005
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/jama.2016.0287$$uSinger M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801–810. https://doi.org/10.1001/jama.2016.0287
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s12028-013-9848-8$$uHuntgeburth M, Adler C, Rosenkranz S, Zobel C, Haupt WF, Dohmen C, Reuter H (2014) Changes in neuron-specific enolase are more suitable than its absolute serum levels for the prediction of neurologic outcome in hypothermia-treated patients with out-of-hospital cardiac arrest. Neurocrit Care 20:358–366: https://doi.org/10.1007/s12028-013-9848-8
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/0009-8981(89)90268-4$$uKaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W (1989) Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183:13–31. https://doi.org/10.1016/0009-8981(89)90268-4
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1161/01.str.30.8.1598$$uSchoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN (1999) Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30:1598–1603. https://doi.org/10.1161/01.str.30.8.1598
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/0009-8981(84)90295-x$$uDay IN, Thompson RJ (1984) Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14–3–3 protein in circulating human blood cells. Clin Chim Acta 136:219–228. https://doi.org/10.1016/0009-8981(84)90295-x
000904377 999C5 $$1E Kaiser$$2Crossref$$9-- missing cx lookup --$$a10.1016/0009-8981(89)90268-4$$p13 -$$tClin Chim Acta$$uKaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W (1998) Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183:13–31$$v183$$y1998
000904377 999C5 $$1PJ Marangos$$2Crossref$$9-- missing cx lookup --$$a10.1111/j.1471-4159.1980.tb09967.x$$p1254 -$$tJ Neurochem$$uMarangos PJ, Campbell IC, Schmechel DE, Murphy DL, Goodwin FK (1980) Blood platelets contain a neurone specific enolase subunit. J Neurochem 34:1254–1258$$v34$$y1980
000904377 999C5 $$1M Aghabarary$$2Crossref$$uAghabarary M, Dehghan Nayeri N (2016) Medical futility and its challenges: a review study. J Med Ethics Hist Med 9:11$$y2016
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1136/medethics-2011-100479$$uJox RJ, Schaider A, Marckmann G, Borasio GD (2012) Medical futility at the end of life: the perspectives of intensive care and palliative care clinicians. J Med Ethics 38:540–545. https://doi.org/10.1136/medethics-2011-100479
000904377 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00415-010-5882-z$$uDemertzi A, Ledoux D, Bruno MA, Vanhaudenhuyse A, Gosseries O, Soddu A, Schnakers C, Moonen G, Laureys S (2011) Attitudes towards end-of-life issues in disorders of consciousness: a European survey. J Neurol 258:1058–1065. https://doi.org/10.1007/s00415-010-5882-z